PLUS THERAPEUTICS, INC. Quarterly Revenues in USD from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Plus Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q2 2010 to Q2 2025.
  • Plus Therapeutics, Inc. Revenues for the quarter ending June 30, 2025 was $1.39M, a 8.68% increase year-over-year.
  • Plus Therapeutics, Inc. annual Revenues for 2024 was $5.82M, a 18.5% increase from 2023.
  • Plus Therapeutics, Inc. annual Revenues for 2023 was $4.91M.
  • Plus Therapeutics, Inc. annual Revenues for 2017 was $2.69M, a 42.2% decline from 2016.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $1.39M +$111K +8.68% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $1.06M -$618K -36.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-30
Q2 2024 $1.28M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $1.68M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-30
Q2 2018 $2.52M $660K -$309K -31.9% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $2.83M $731K +$140K +23.7% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $2.69M $662K -$804K -54.8% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-09
Q3 2017 $3.49M $467K -$264K -36.1% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-09
Q2 2017 $3.76M $969K -$157K -13.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $3.91M $591K -$742K -55.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $4.66M $1.47M -$90K -5.78% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $4.75M $731K -$35K -4.57% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 $4.78M $1.13M -$488K -30.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 $5.27M $1.33M +$431K +47.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 $4.84M $1.56M -$913K -37% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 $5.75M $766K +$248K +47.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 $5.5M $1.61M +$679K +72.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 $4.82M $902K -$129K -12.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q4 2014 $4.95M $2.47M -$237K -8.76% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 $5.19M $518K -$1.1M -67.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 $6.29M $935K -$473K -33.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 $6.76M $1.03M -$361K -25.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 $7.12M $2.71M -$1.26M -31.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $8.38M $1.62M +$302K +23% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 $8.08M $1.41M -$539K -27.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 $8.62M $1.39M -$89K -6.01% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 $8.71M $3.97M +$1.89M +91.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $6.82M $1.31M -$820K -38.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $7.64M $1.95M -$464K -19.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $8.1M $1.48M +$119K +8.74% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $7.98M $2.08M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 $2.13M +$615K +40.5% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 $2.41M +$320K +15.3% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 $1.36M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 $1.52M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $2.09M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.